Category: lorlatinib

Lorlatinib (informal transliteration of the Chinese name) is a third-generation ALK/ROS1 inhibitor with potent, highly selective and brain-permeable properties that shows extraordinary efficacy potential in patients with ALK or ROS1-positive…

　　Osteoporosis is a systemic bone disease associated with the loss of bone calcium in the body, which can easily lead to fractures, low back pain, shortening of height, and hunchback…